BAX — Baxter International Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for Baxter International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	12,146	10,057	10,360	10,636	11,244
Cost of Revenue
Gross Profit	4,773	3,564	4,180	4,046	3,450
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	10,851	12,902	9,687	10,622	11,541
Operating Profit	1,295	-2,845	673	14	-297
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,116	-3,248	242	-289	-505
Provision for Income Taxes
Net Income After Taxes	1,033	-3,113	181	-326	-900
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	1,284	-2,433	2,656	-649	-957
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,284	-2,433	2,656	-649	-957
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.58	0.772	0.915	1.06	0.526
Dividends per Share